Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33991 | 0.90 | SIGMAR1 (0.52) | SIGMAR1TAAR1SLC18A2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL5653344 | 0.88 | SIGMAR1 (0.50) | SIGMAR1TAAR1SLC18A2MEN1KMT2A | |
| SCHEMBL497585 | 0.74 | SIGMAR1 (0.46) | SIGMAR1TAAR1SLC18A2MEN1KMT2A | |
| SCHEMBL20061130 | 0.74 | SIGMAR1 (0.56) | SIGMAR1TAAR1SLC18A2MEN1KMT2A | |
| SCHEMBL20061148 | 0.74 | SIGMAR1 (0.56) | SIGMAR1TAAR1SLC18A2MEN1KMT2A | |
| SCHEMBL28281562 | 0.72 | SIGMAR1 (0.52) | SIGMAR1TAAR1SLC18A2MEN1KMT2A | |
| SCHEMBL27740328 | 0.71 | SLC6A4 (0.54) | SIGMAR1TAAR1SLC18A2MEN1KMT2A | |
| SCHEMBL17479478 | 0.71 | SIGMAR1 (0.50) | SIGMAR1TAAR1SLC18A2MEN1KMT2A | |
| SCHEMBL30624762 | 0.71 | SIGMAR1 (0.71) | SIGMAR1TAAR1SLC18A2MEN1KMT2A | |
| SCHEMBL21243273 | 0.71 | SIGMAR1 (0.73) | SIGMAR1TAAR1SLC18A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4396305-A1 | SYNTHESIS OF MDMA OR ITS OPTICALLY ACTIVE (R)- OR (S)-MDMA ISOMERS | Empathibio, Inc. (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2023081899-A1 | ISOTOPICALLY ENRICHED N-METHYL-1,3-BENZODIOXOLYLBUTANAMINE (MBDB) AND STEREOISOMERS THEREOF | TERRAN BIOSCIENCES, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023034510-A1 | SYNTHESIS OF MDMA OR ITS OPTICALLY ACTIVE ( R)- OR ( S)-MDMA ISOMERS | ATAI Life Sciences AG (DE) | 2023-03-09 | — | — | WO | disclosed |
| EP-2053919-B1 | METHOD OF REDUCING NEURONAL CELL DAMAGE | UNIV MONTANA (US) | 2013-12-25 | — | — | EP | disclosed |
| US-20100249242-A1 | METHOD OF REDUCING NEURONAL CELL DAMAGE | THE UNIVERSITY OF MONTANA | 2010-09-30 | — | — | US | disclosed |
| EP-2053919-A2 | METHOD OF REDUCING NEURONAL CELL DAMAGE | THE UNIVERSITY OF MONTANA (US) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008024660-A2 | METHOD OF REDUCING NEURONAL CELL DAMAGE | THE UNIVERSITY OF MONTANA (US) | 2008-02-28 | — | — | WO | disclosed |